Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria

Medical Journal of Australia

Volumn 171, Issue 3, 1999, Pages 133-136

  Grayson, M Lindsay ^a,b   Grabsch, Elizabeth A ^a   Johnson, Paul D R ^a,c   Olden, Dianne ^a   Aberline, Melissa ^a   Li, H Y ^d   Hogg, Geoffrey ^d   Abbott, Marguerite ^a   Kerr, Peter G ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BACITRACIN; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL INFECTION; DRUG USE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FECES ANALYSIS; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PERITONEAL DIALYSIS; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SCREENING;

EID: 0033517018     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1999.tb123564.x     Document Type: Article

References (22)

1. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-161.
2. Uttley AHC, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; 1: 57-58.
3. Clark NC, Cooksey RC, Hill BC, et al. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother 1993; 37: 2311-2317.
4. Centers for Disease Control. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993; 42: 597-599.
5. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993; 342: 76-79.
6. Boyce JM. Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures. Infect Dis Clin North Am 1997; 11: 367-384.
7. Kamarulzaman A, Tosolini FA, Boquest AL, et al. Vancomycin resistant Enterococcus faecium infection in a liver transplant recipient [abstract]. Aust N Z J Med 1995; 25: 560.
8. Eliopoulos GM. Vancomycin-resistant enterococci. Mechanism and clinical relevance. Infect Dis Clin North Am 1997; 11: 851-865.
9. Bell J, Turnidge J, Coombs G, O'Brien F. Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Commun Dis Intell 1998; 22: 249-252.
10. Bell JM, Paton JC, Turnidge J. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol 1998; 36: 2187-2190.
11. Standing Committee on Infection Control (SCIC), Department of Human Services, Victoria. Guidelines for the management of patients with confirmed vancomycin-resistant enterococci (VRE) infection/colonisation. Melbourne: Department of Human Services, 1996.
12. Moellering RC Jr. The Garrod lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Chemother 1991; 28:1-12.
13. Weinstein JW, Tallapragada S, Farrel P, Dembry L-M. Comparison of rectal and perirectal swabs for detection of colonisation with vancomycin-resistant enterococci. J Clin Microbiol 1996; 34: 210-212.
14. Facklam RR, Sahm DF. Enterococcus. In: Murray PR, Baron EJ, Pfaller MA, et al, editors. Manual of clinical microbiology. 6th ed. Washington: ASM Press, 1995: 308-314.
15. Dutka-Malen A, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33: 24-27.
16. Miranda AG, Singh KV, Murray BE. A fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J Clin Microbiol 1991; 29: 2752-2757.
17. O'Donovan CA, Fan-Havard P, Tecson-Tumang FT, et al. Enteric eradication of vancomycin-resistant Enterococcus laecium with oral bacitracin. Diagn Microbiol Infect Dis 1994; 18: 105-109.
18. Chia JKS, Nakata MM, Park SS, et al. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1995; 21: 1520.
19. Jordens JZ, Bates J, Griffith DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antmicrob Chemother 1994; 34: 515-528.
20. Montecalvo MA, deLaencastre H, Carraher M, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995; 16: 680-685.
21. Leclercq R, Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis 1997; 24: 545-556.
22. Perichon B, Reynolds P. Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 1997; 41: 2016-2018.